199 related articles for article (PubMed ID: 1658553)
1. Use and specificity of genistein as inhibitor of protein-tyrosine kinases.
Akiyama T; Ogawara H
Methods Enzymol; 1991; 201():362-70. PubMed ID: 1658553
[No Abstract] [Full Text] [Related]
2. Structural studies on bioactive compounds. 23. Synthesis of polyhydroxylated 2-phenylbenzothiazoles and a comparison of their cytotoxicities and pharmacological properties with genistein and quercetin.
Stevens MF; McCall CJ; Lelieveld P; Alexander P; Richter A; Davies DE
J Med Chem; 1994 May; 37(11):1689-95. PubMed ID: 8201603
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of action in NIH-3T3 cells of genistein, an inhibitor of EGF receptor tyrosine kinase activity.
Linassier C; Pierre M; Le Pecq JB; Pierre J
Biochem Pharmacol; 1990 Jan; 39(1):187-93. PubMed ID: 2153378
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cellular phosphatidylinositol turnover by psi-tectorigenin.
Imoto M; Yamashita T; Sawa T; Kurasawa S; Naganawa H; Takeuchi T; Bao-quan Z; Umezawa K
FEBS Lett; 1988 Mar; 230(1-2):43-6. PubMed ID: 3258253
[TBL] [Abstract][Full Text] [Related]
5. Effects of inhibitors of protein tyrosine kinase activity and/or phosphatidylinositol turnover on differentiation of some human myelomonocytic leukemia cells.
Makishima M; Honma Y; Hozumi M; Sampi K; Hattori M; Umezawa K; Motoyoshi K
Leuk Res; 1991; 15(8):701-8. PubMed ID: 1895751
[TBL] [Abstract][Full Text] [Related]
6. Genistein, a specific inhibitor of tyrosine-specific protein kinases.
Akiyama T; Ishida J; Nakagawa S; Ogawara H; Watanabe S; Itoh N; Shibuya M; Fukami Y
J Biol Chem; 1987 Apr; 262(12):5592-5. PubMed ID: 3106339
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of protein-tyrosine kinases by tyrphostins.
Levitzki A; Gazit A; Osherov N; Posner I; Gilon C
Methods Enzymol; 1991; 201():347-61. PubMed ID: 1658552
[No Abstract] [Full Text] [Related]
8. Use of erbstatin as protein-tyrosine kinase inhibitor.
Umezawa K; Imoto M
Methods Enzymol; 1991; 201():379-85. PubMed ID: 1658555
[No Abstract] [Full Text] [Related]
9. A specific inhibitor for tyrosine protein kinase from Pseudomonas.
Ogawara H; Akiyama T; Ishida J; Watanabe S; Suzuki K
J Antibiot (Tokyo); 1986 Apr; 39(4):606-8. PubMed ID: 3710920
[No Abstract] [Full Text] [Related]
10. Inhibitors of protein kinases induce differentiation in human neuroblastoma cell lines.
Rocchi P; Ferreri AM; Simone G; Magrini E; Cavallazzi L; Paolucci G
Anticancer Res; 1995; 15(4):1381-5. PubMed ID: 7654025
[TBL] [Abstract][Full Text] [Related]
11. Inhibitors for protein-tyrosine kinases, ST638 and genistein: induce differentiation of mouse erythroleukemia cells in a synergistic manner.
Watanabe T; Shiraishi T; Sasaki H; Oishi M
Exp Cell Res; 1989 Aug; 183(2):335-42. PubMed ID: 2767154
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II.
Markovits J; Linassier C; Fossé P; Couprie J; Pierre J; Jacquemin-Sablon A; Saucier JM; Le Pecq JB; Larsen AK
Cancer Res; 1989 Sep; 49(18):5111-7. PubMed ID: 2548712
[TBL] [Abstract][Full Text] [Related]
13. Increased neurite outgrowth induced by inhibition of protein tyrosine kinase activity in PC12 pheochromocytoma cells.
Miller DR; Lee GM; Maness PF
J Neurochem; 1993 Jun; 60(6):2134-44. PubMed ID: 7684068
[TBL] [Abstract][Full Text] [Related]
14. Induction of in vitro differentiation of mouse erythroleukemia cells by genistein, an inhibitor of tyrosine protein kinases.
Watanabe T; Kondo K; Oishi M
Cancer Res; 1991 Feb; 51(3):764-8. PubMed ID: 1988116
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of tyrosine kinase activity decreases expression of surfactant protein A in a human lung adenocarcinoma cell line independent of epidermal growth factor receptor.
Klein JM; McCarthy TA
Biochim Biophys Acta; 1997 Mar; 1355(3):218-30. PubMed ID: 9060993
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of tyrosine protein kinase activity by synthetic isoflavones and flavones.
Ogawara H; Akiyama T; Watanabe S; Ito N; Kobori M; Seoda Y
J Antibiot (Tokyo); 1989 Feb; 42(2):340-3. PubMed ID: 2538411
[No Abstract] [Full Text] [Related]
17. Protein kinase inhibitors exert stage specific and inducer dependent effects on HL-60 cell differentiation.
Savickiene J; Gineitis A; Shanbhag VP; Stigbrand T
Anticancer Res; 1995; 15(3):687-92. PubMed ID: 7645944
[TBL] [Abstract][Full Text] [Related]
18. Effect of genistein on topoisomerase activity and on the growth of [Val 12]Ha-ras-transformed NIH 3T3 cells.
Okura A; Arakawa H; Oka H; Yoshinari T; Monden Y
Biochem Biophys Res Commun; 1988 Nov; 157(1):183-9. PubMed ID: 2848517
[TBL] [Abstract][Full Text] [Related]
19. Regulation of glycolipid sulfotransferase by tyrosine kinases in human renal cancer cells.
Balbaa M; Honke K; Makita A
Biochim Biophys Acta; 1996 Jan; 1299(1):141-5. PubMed ID: 8555246
[TBL] [Abstract][Full Text] [Related]
20. Effect of genistein, a tyrosine kinase inhibitor, on U46619-induced phosphoinositide phosphorylation in human platelets.
Gaudette DC; Holub BJ
Biochem Biophys Res Commun; 1990 Jul; 170(1):238-42. PubMed ID: 2164806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
